Furthermore, IBD represents a risk factor for the development of colorectal cancer, and inflammation-associated estrogen receptor dysregulation might be one of the factors linking chronic intestinal diseases to neoplastic transformation. This evidence concerns the gene ESR1 and colorectal cancer.